Cargando…
Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1)
OBJECTIVES: Brain tumours lead to significant morbidity including a neurocognitive, physical and psychological burden of disease. The extent to which they impact the multiple domains of health is difficult to capture leading to a significant degree of unmet needs. Mobile health tools such as Vinehea...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791405/ https://www.ncbi.nlm.nih.gov/pubmed/36579146 http://dx.doi.org/10.1136/bmjsit-2021-000130 |
_version_ | 1784859400513519616 |
---|---|
author | Gvozdanovic, Andrew Jozsa, Felix Fersht, Naomi Grover, Patrick James Kirby, Georgina Kitchen, Neil Mangiapelo, Riccardo McEvoy, Andrew Miserocchi, Anna Patel, Rayna Thorne, Lewis Williams, Norman Kosmin, Michael Marcus, Hani J |
author_facet | Gvozdanovic, Andrew Jozsa, Felix Fersht, Naomi Grover, Patrick James Kirby, Georgina Kitchen, Neil Mangiapelo, Riccardo McEvoy, Andrew Miserocchi, Anna Patel, Rayna Thorne, Lewis Williams, Norman Kosmin, Michael Marcus, Hani J |
author_sort | Gvozdanovic, Andrew |
collection | PubMed |
description | OBJECTIVES: Brain tumours lead to significant morbidity including a neurocognitive, physical and psychological burden of disease. The extent to which they impact the multiple domains of health is difficult to capture leading to a significant degree of unmet needs. Mobile health tools such as Vinehealth have the potential to identify and address these needs through real-world data generation and delivery of personalised educational material and therapies. We aimed to establish the feasibility of Vinehealth integration into brain tumour care, its ability to collect real-world and (electronic) patient-recorded outcome (ePRO) data, and subjective improvement in care. DESIGN: A mixed-methodology IDEAL stage 1 study. SETTING: A single tertiary care centre. PARTICIPANTS: Six patients consented and four downloaded and engaged with the mHealth application throughout the 12 weeks of the study. MAIN OUTCOME MEASURES: Over a 12-week period, we collected real-world and ePRO data via Vinehealth. We assessed qualitative feedback from mixed-methodology surveys and semistructured interviews at recruitment and after 2 weeks. RESULTS: 565 data points were captured including, but not limited to: symptoms, activity, well-being and medication. EORTC QLQ-BN20 and EQ-5D-5L completion rates (54% and 46%) were impacted by technical issues; 100% completion rates were seen when ePROs were received. More brain cancer tumour-specific content was requested. All participants recommended the application and felt it improved care. CONCLUSIONS: Our findings indicate value in an application to holistically support patients living with brain cancer tumours and established the feasibility and safety of further studies to more rigorously assess this. |
format | Online Article Text |
id | pubmed-9791405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-97914052022-12-27 Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) Gvozdanovic, Andrew Jozsa, Felix Fersht, Naomi Grover, Patrick James Kirby, Georgina Kitchen, Neil Mangiapelo, Riccardo McEvoy, Andrew Miserocchi, Anna Patel, Rayna Thorne, Lewis Williams, Norman Kosmin, Michael Marcus, Hani J BMJ Surg Interv Health Technol Original Research OBJECTIVES: Brain tumours lead to significant morbidity including a neurocognitive, physical and psychological burden of disease. The extent to which they impact the multiple domains of health is difficult to capture leading to a significant degree of unmet needs. Mobile health tools such as Vinehealth have the potential to identify and address these needs through real-world data generation and delivery of personalised educational material and therapies. We aimed to establish the feasibility of Vinehealth integration into brain tumour care, its ability to collect real-world and (electronic) patient-recorded outcome (ePRO) data, and subjective improvement in care. DESIGN: A mixed-methodology IDEAL stage 1 study. SETTING: A single tertiary care centre. PARTICIPANTS: Six patients consented and four downloaded and engaged with the mHealth application throughout the 12 weeks of the study. MAIN OUTCOME MEASURES: Over a 12-week period, we collected real-world and ePRO data via Vinehealth. We assessed qualitative feedback from mixed-methodology surveys and semistructured interviews at recruitment and after 2 weeks. RESULTS: 565 data points were captured including, but not limited to: symptoms, activity, well-being and medication. EORTC QLQ-BN20 and EQ-5D-5L completion rates (54% and 46%) were impacted by technical issues; 100% completion rates were seen when ePROs were received. More brain cancer tumour-specific content was requested. All participants recommended the application and felt it improved care. CONCLUSIONS: Our findings indicate value in an application to holistically support patients living with brain cancer tumours and established the feasibility and safety of further studies to more rigorously assess this. BMJ Publishing Group 2022-12-22 /pmc/articles/PMC9791405/ /pubmed/36579146 http://dx.doi.org/10.1136/bmjsit-2021-000130 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Gvozdanovic, Andrew Jozsa, Felix Fersht, Naomi Grover, Patrick James Kirby, Georgina Kitchen, Neil Mangiapelo, Riccardo McEvoy, Andrew Miserocchi, Anna Patel, Rayna Thorne, Lewis Williams, Norman Kosmin, Michael Marcus, Hani J Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) |
title | Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) |
title_full | Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) |
title_fullStr | Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) |
title_full_unstemmed | Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) |
title_short | Integration of a personalised mobile health (mHealth) application into the care of patients with brain tumours: proof-of-concept study (IDEAL stage 1) |
title_sort | integration of a personalised mobile health (mhealth) application into the care of patients with brain tumours: proof-of-concept study (ideal stage 1) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791405/ https://www.ncbi.nlm.nih.gov/pubmed/36579146 http://dx.doi.org/10.1136/bmjsit-2021-000130 |
work_keys_str_mv | AT gvozdanovicandrew integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT jozsafelix integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT fershtnaomi integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT groverpatrickjames integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT kirbygeorgina integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT kitchenneil integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT mangiapeloriccardo integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT mcevoyandrew integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT miserocchianna integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT patelrayna integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT thornelewis integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT williamsnorman integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT kosminmichael integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 AT marcushanij integrationofapersonalisedmobilehealthmhealthapplicationintothecareofpatientswithbraintumoursproofofconceptstudyidealstage1 |